Search Results
Results found for "Tack Kuntz"
- ⛵Sailing the GPCR Seas: Your Weekly Research Voyage! ⦿ Nov 11 - 17, 2024
GPCR University 🎥 Access to the recorded classes of GPCR Courses and talks from Symposia 💲 Discounted with AEF0217 in young adults with Down syndrome Novartis pays Schrödinger $150M, bets billions on the back
- Structural landscape of the Chemokine Receptor system
CKRs can be classified into typical CKRs, atypical CKRs (ACKRs) which lack G-protein signaling, and viral variants of CCL15, namely CCL15L (residues 26-92) and CCL15M (residues 27-92), while the third structure lacks
- From Failed Experiments to Predictive GPCR Models
His lab has already begun using AlphaFold models to identify ligands for targets that lack experimental
- Enzyme Inhibition Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery
In every lab, candidates fail not because they lack potency at a receptor, but because they stumble at
- Hop in the Time Machine with GPCR: Unraveling the Future of Research! ⦿ Nov 24 - Dec 1, 2024
We're zooming back to the future of GPCR discoveries. We're about to reveal our University CheatSheet —a sneaky peek at all our talks, presentations, and courses
- 📰 GPCR Weekly News
We're excited to be back and share our weekly newsletter! Tracking N- and C-termini of C. elegans polycystin-1 reveals their distinct targeting requirements and
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
models, such as deep learning neural networks, are often referred to as "black boxes" because they lack databases from experimental labs and new AI techniques will allow more associations and will promote multi-task
- Decoding β-Arrestins: from Structure to function
Despite their contributions, these methods often lack cellular auxiliary structures and proteins.




